Cargando…

Risk factors for second‐line dactinomycin failure after methotrexate treatment for low‐risk gestational trophoblastic neoplasia: a retrospective study

OBJECTIVE: To find risk factors for second‐line dactinomycin failure in patients with low‐risk gestational trophoblastic neoplasia (GTN). DESIGN: Retrospective multicentre study. SETTING: Tertiary reference centre. POPULATION: Patients with low‐risk GTN, treated with dactinomycin after methotrexate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoeijmakers, YM, Sweep, FCGJ, Lok, CAR, Ottevanger, PB
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Gynaecological Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383780/ https://www.ncbi.nlm.nih.gov/pubmed/32141676 http://dx.doi.org/10.1111/1471-0528.16198

Ejemplares similares

The psychological impact of gestational trophoblastic disease: a prospective observational multicentre cohort study
por: Blok, LJ, et al.
Publicado: (2021)

Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease
por: Dobson, L S, et al.
Publicado: (2000)

Serum human chorionic gonadotropin ratios for the detection of etoposide, methotrexate, dactinomycin, cyclophosphamide, and vincristine resistance in high‐risk gestational trophoblastic neoplasia
por: Sirimusika, Nathapol, et al.
Publicado: (2022)

Consolidation chemotherapy in postmolar low-risk gestational trophoblastic neoplasia: a systematic review protocol
por: Branco-Silva, Mariza, et al.
Publicado: (2022)

Differences in Administration of Methotrexate and Impact on Outcome in Low-Risk Gestational Trophoblastic Neoplasia
por: Wallin, Emelie, et al.
Publicado: (2022)

Methotrexate pneumonitis in a patient with gestational trophoblastic neoplasia
por: Agarwal, M, et al.
Publicado: (2022)

Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide
por: Kanno, Toshiyuki, et al.
Publicado: (2018)

PD‐L1 in gestational trophoblastic disease: an antibody evaluation
por: Hoeijmakers, Yvonne M., et al.
Publicado: (2022)

Effect of Combination Therapy of Methotrexate with Vitamin A in Patients with Low Risk GTN (Gestational Trophoblastic Neoplasia)
por: Ghasemian, Sedigheh, et al.
Publicado: (2018)

Challenges in the Treatment of Low-risk Gestational Trophoblastic Neoplasia
por: Braga, Antonio, et al.
Publicado: (2021)

The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy
por: Wu, Xiaodong, et al.
Publicado: (2020)

The Evolution of Methotrexate as a Treatment for Ectopic Pregnancy and Gestational Trophoblastic Neoplasia: A Review
por: Skubisz, Monika M., et al.
Publicado: (2012)

Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia
por: Agarwal, R, et al.
Publicado: (2012)

Gestational trophoblastic neoplasia in the 1990s.
por: Goldstein, D. P.
Publicado: (1991)

Comparison of the efficacy of methotrexate and actinomycin D in the treatment of patients with stage I low risk gestational trophoblastic neoplasia (GTN)
por: Shahbazian, Nahid, et al.
Publicado: (2014)

Single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
por: Mousavi Seresht, Leila, et al.
Publicado: (2023)

Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report
por: Das, Sunil Kumar, et al.
Publicado: (2022)

Spontaneous regression of gestational trophoblastic neoplasia
por: Niimi, Kaoru, et al.
Publicado: (2017)

Dysgerminoma Masquerading as Gestational Trophoblastic Neoplasia
por: Blackwell, Conner, et al.
Publicado: (2023)

Monotherapy for low-risk gestational trophoblastic neoplasia with score 5-6
por: Kemin, Li, et al.
Publicado: (2022)

Resistance to single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
por: Sheikhhasani, Shahrzad, et al.
Publicado: (2023)

Repeat Curettage In the Management of Low-Risk Gestational Trophoblastic Neoplasia (GTN)
por: Aminimoghaddam, Soheila, et al.
Publicado: (2023)

Doppler‐based predictive model for methotrexate resistance in low‐risk gestational trophoblastic neoplasia with myometrial invasion: prospective study of 147 patients
por: Qin, J., et al.
Publicado: (2021)

Gestational trophoblastic neoplasia, management as per risk stratification in a developing country
por: Hussain, Ansar, et al.
Publicado: (2016)

Effect of actinomycin D on ovarian reserve in low-risk gestational trophoblastic neoplasia
por: Xue, Wei, et al.
Publicado: (2023)

A review on management of gestational trophoblastic neoplasia
por: Sharami, Seyedeh Reyhaneh Yousefi, et al.
Publicado: (2020)

The Proper Treatment of Tubal Gestation
Publicado: (1908)

Factors Predicting Severe Myelosuppression and Its Influence on Fertility in Patients with Low-Risk Gestational Trophoblastic Neoplasia Receiving Single-Agent Methotrexate Chemotherapy
por: Tu, Xiaoyu, et al.
Publicado: (2020)

Outcome of treatment with EMA/EP (etoposide methotrexate and actinomycin-D/ etoposide and cisplatin) regimen in gestational trophoblastic neoplasia
por: Aminimoghaddam, Soheila, et al.
Publicado: (2018)

LINE-1 Methylation Patterns as a Predictor of Postmolar Gestational Trophoblastic Neoplasia
por: Lertkhachonsuk, Ruangsak, et al.
Publicado: (2015)

Dactinomycin/vincristine: Various toxicities: case report
Publicado: (2021)

Relationship between weight retention at 6 weeks postpartum and the risk of large-for-gestational age birth in a second pregnancy in China: a retrospective cohort study
por: Liu, Jing, et al.
Publicado: (2021)

Methotrexate-induced hemothorax in a woman with low-risk metastatic gestational trophoblastic disease
por: Ohki, Yuji, et al.
Publicado: (2019)

Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia
por: Li, Lei, et al.
Publicado: (2018)

Management and risk factors of recurrent gestational trophoblastic neoplasia: An update from 2004 to 2017
por: Kong, Yujia, et al.
Publicado: (2020)

High-Risk Gestational Trophoblastic Neoplasia from a Homozygous NLRP7 Mutation
por: Kopelman, Zachary A., et al.
Publicado: (2021)

Acute pulmonary complications in the setting of high risk gestational trophoblastic neoplasia and induction of chemotherapy
por: Khadraoui, Hanaa, et al.
Publicado: (2023)

Human Chorionic Gonadotropin Polypeptide Nanoparticle Drug Delivery System Improves Methotrexate Efficacy in Gestational Trophoblastic Neoplasia in vitro
por: Cong, Qing, et al.
Publicado: (2021)

Current Chemotherapeutic Management of Patients with Gestational Trophoblastic Neoplasia
por: May, Taymaa, et al.
Publicado: (2011)

Role of surgical therapy in the management of gestational trophoblastic neoplasia
por: Eoh, Kyung Jin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7gqu1qod6gh927hsadu2aotluo